Analysts Anticipate Humana Inc (HUM) Will Post Earnings of $2.00 Per Share

Brokerages predict that Humana Inc (NYSE:HUM) will post $2.00 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Humana’s earnings. The lowest EPS estimate is $1.95 and the highest is $2.06. Humana posted earnings of $2.09 per share during the same quarter last year, which indicates a negative year-over-year growth rate of 4.3%. The company is scheduled to issue its next quarterly earnings report on Wednesday, February 14th.

According to Zacks, analysts expect that Humana will report full-year earnings of $11.63 per share for the current fiscal year, with EPS estimates ranging from $11.60 to $11.69. For the next fiscal year, analysts forecast that the company will post earnings of $12.12 per share, with EPS estimates ranging from $11.95 to $12.36. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that follow Humana.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The company had revenue of $13.28 billion during the quarter, compared to analyst estimates of $13.41 billion. During the same quarter in the previous year, the firm earned $3.18 earnings per share. Humana’s revenue was down 3.0% on a year-over-year basis.

Several research analysts have recently commented on HUM shares. BMO Capital Markets boosted their price objective on Humana from $290.00 to $300.00 and gave the stock an “outperform” rating in a report on Friday, November 10th. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Royal Bank of Canada reissued a “sector perform” rating and set a $242.00 price objective (down previously from $245.00) on shares of Humana in a report on Thursday, November 9th. Credit Suisse Group cut their price objective on Humana from $256.00 to $246.00 and set a “neutral” rating for the company in a report on Friday, November 10th. Finally, Zacks Investment Research lowered Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 17th. Twelve investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $256.30.

Humana (NYSE HUM) opened at $248.15 on Thursday. Humana has a twelve month low of $186.25 and a twelve month high of $264.56. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $35,000.72, a PE ratio of 19.52, a PEG ratio of 1.68 and a beta of 0.88.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s dividend payout ratio (DPR) is presently 12.59%.

Humana announced that its board has authorized a share repurchase plan on Thursday, December 14th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the insurance provider to reacquire shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company’s board believes its stock is undervalued.

In other news, SVP Brian P. Leclaire sold 1,679 shares of the stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the sale, the senior vice president now owns 9,888 shares of the company’s stock, valued at $2,432,151.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Jody L. Bilney sold 7,054 shares of the stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $247.89, for a total value of $1,748,616.06. Following the sale, the senior vice president now directly owns 11,704 shares of the company’s stock, valued at approximately $2,901,304.56. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,115 shares of company stock valued at $2,501,627. Insiders own 0.80% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Koch Industries Inc. bought a new position in shares of Humana during the second quarter valued at approximately $404,000. Adviser Investments LLC bought a new position in shares of Humana during the third quarter valued at approximately $635,000. Teachers Advisors LLC raised its holdings in shares of Humana by 31.6% during the second quarter. Teachers Advisors LLC now owns 630,835 shares of the insurance provider’s stock valued at $151,792,000 after acquiring an additional 151,603 shares in the last quarter. Prisma Capital Partners LP bought a new position in shares of Humana during the second quarter valued at approximately $7,122,000. Finally, Wells Fargo & Company MN raised its holdings in shares of Humana by 10.0% during the third quarter. Wells Fargo & Company MN now owns 1,653,318 shares of the insurance provider’s stock valued at $402,799,000 after acquiring an additional 150,173 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://www.com-unik.info/2017/12/28/analysts-anticipate-humana-inc-hum-will-post-earnings-of-2-00-per-share.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get a free copy of the Zacks research report on Humana (HUM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit